Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells
Julia Wanek(University of Salzburg), Tobias Kiesslich(Paracelsus Medical University)
Cited by 53
Related Papers
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
|Oncotarget|2015|42
Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients
|International Journal of Molecular Sciences|2016|17